CN104127752B - 治疗外感风热型肾小球肾炎血尿的中药 - Google Patents
治疗外感风热型肾小球肾炎血尿的中药 Download PDFInfo
- Publication number
- CN104127752B CN104127752B CN201410417155.5A CN201410417155A CN104127752B CN 104127752 B CN104127752 B CN 104127752B CN 201410417155 A CN201410417155 A CN 201410417155A CN 104127752 B CN104127752 B CN 104127752B
- Authority
- CN
- China
- Prior art keywords
- radix
- blood
- affection
- chinese medicine
- glomerulonephritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 86
- 239000008280 blood Substances 0.000 title claims abstract description 86
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 210000002700 urine Anatomy 0.000 title claims abstract description 28
- 206010018364 Glomerulonephritis Diseases 0.000 title claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 41
- 241000283966 Pholidota <mammal> Species 0.000 claims abstract description 26
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 19
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 19
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 19
- 239000009636 Huang Qi Substances 0.000 claims abstract description 18
- 244000197580 Poria cocos Species 0.000 claims abstract description 18
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 18
- 240000005528 Arctium lappa Species 0.000 claims abstract description 17
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 17
- 240000001579 Cirsium arvense Species 0.000 claims abstract description 17
- 235000005918 Cirsium arvense Nutrition 0.000 claims abstract description 17
- 241000196133 Dryopteris Species 0.000 claims abstract description 17
- 239000010231 banlangen Substances 0.000 claims abstract description 17
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 16
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 16
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 244000025254 Cannabis sativa Species 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 241001499733 Plantago asiatica Species 0.000 abstract description 14
- 210000002966 serum Anatomy 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 238000002562 urinalysis Methods 0.000 description 35
- 108090000623 proteins and genes Proteins 0.000 description 23
- 102000004169 proteins and genes Human genes 0.000 description 23
- 208000022182 gross hematuria Diseases 0.000 description 18
- 201000010099 disease Diseases 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- 206010013789 Dry throat Diseases 0.000 description 14
- 210000003743 erythrocyte Anatomy 0.000 description 14
- 206010030113 Oedema Diseases 0.000 description 11
- 230000023597 hemostasis Effects 0.000 description 11
- 238000011862 kidney biopsy Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 230000007170 pathology Effects 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 206010029164 Nephrotic syndrome Diseases 0.000 description 9
- 238000009534 blood test Methods 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 238000002651 drug therapy Methods 0.000 description 9
- 210000003141 lower extremity Anatomy 0.000 description 9
- 208000009928 nephrosis Diseases 0.000 description 9
- 231100001027 nephrosis Toxicity 0.000 description 9
- 239000011701 zinc Substances 0.000 description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 8
- 210000000744 eyelid Anatomy 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 229910052725 zinc Inorganic materials 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 7
- 238000003748 differential diagnosis Methods 0.000 description 7
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 6
- 230000036737 immune function Effects 0.000 description 6
- 230000003907 kidney function Effects 0.000 description 6
- 239000010949 copper Substances 0.000 description 5
- 230000003908 liver function Effects 0.000 description 5
- 229940090007 persantine Drugs 0.000 description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 108010061435 Enalapril Proteins 0.000 description 4
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 4
- 239000000370 acceptor Substances 0.000 description 4
- 230000004596 appetite loss Effects 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 4
- 229960000873 enalapril Drugs 0.000 description 4
- 235000021266 loss of appetite Nutrition 0.000 description 4
- 208000019017 loss of appetite Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 3
- 206010021148 Hypozincaemia Diseases 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000483399 Ipimorpha retusa Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 244000131316 Panax pseudoginseng Species 0.000 description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 2
- 239000000729 antidote Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical group C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 2
- 235000021286 stilbenes Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000209205 Coix Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 241001660870 Cyrtomium Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 206010018366 Glomerulonephritis acute Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010065716 Pharyngeal inflammation Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000271897 Viperidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- GCNLQHANGFOQKY-UHFFFAOYSA-N [C+4].[O-2].[O-2].[Ti+4] Chemical compound [C+4].[O-2].[O-2].[Ti+4] GCNLQHANGFOQKY-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008950 danggui buxue decoction Substances 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001709 ictal effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 231100001028 renal lesion Toxicity 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000036228 toxication Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 239000008530 yinqiaosan Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410417155.5A CN104127752B (zh) | 2014-08-23 | 2014-08-23 | 治疗外感风热型肾小球肾炎血尿的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410417155.5A CN104127752B (zh) | 2014-08-23 | 2014-08-23 | 治疗外感风热型肾小球肾炎血尿的中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104127752A CN104127752A (zh) | 2014-11-05 |
CN104127752B true CN104127752B (zh) | 2018-05-01 |
Family
ID=51800774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410417155.5A Expired - Fee Related CN104127752B (zh) | 2014-08-23 | 2014-08-23 | 治疗外感风热型肾小球肾炎血尿的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104127752B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108403985A (zh) * | 2017-02-10 | 2018-08-17 | 周继伟 | 解毒消炎消肿汤 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101164598A (zh) * | 2007-09-24 | 2008-04-23 | 黄桂宝 | 治疗小儿急性肾炎的中药 |
CN101167997A (zh) * | 2007-11-05 | 2008-04-30 | 张旭明 | 一种用于预防和治疗急慢性湿热病毒型肾炎水肿的中草药口服液凉茶制剂 |
CN101623452A (zh) * | 2008-07-08 | 2010-01-13 | 张成赟 | 一种治疗肾小球肾炎的中药组合物 |
CN103071082A (zh) * | 2012-12-04 | 2013-05-01 | 陈柏林 | 一种治疗慢性肾炎的中药组合物 |
CN103845653A (zh) * | 2014-02-05 | 2014-06-11 | 杨杰 | 一种用于治疗急性肾炎的中药 |
-
2014
- 2014-08-23 CN CN201410417155.5A patent/CN104127752B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101164598A (zh) * | 2007-09-24 | 2008-04-23 | 黄桂宝 | 治疗小儿急性肾炎的中药 |
CN101167997A (zh) * | 2007-11-05 | 2008-04-30 | 张旭明 | 一种用于预防和治疗急慢性湿热病毒型肾炎水肿的中草药口服液凉茶制剂 |
CN101623452A (zh) * | 2008-07-08 | 2010-01-13 | 张成赟 | 一种治疗肾小球肾炎的中药组合物 |
CN103071082A (zh) * | 2012-12-04 | 2013-05-01 | 陈柏林 | 一种治疗慢性肾炎的中药组合物 |
CN103845653A (zh) * | 2014-02-05 | 2014-06-11 | 杨杰 | 一种用于治疗急性肾炎的中药 |
Non-Patent Citations (3)
Title |
---|
急性肾小球肾炎92例临床体会;王艳华 等;《中医药学报》;19970620(第3期);第22页 * |
芪莲解毒汤治疗慢性肾小球肾炎的临床观察;崔梅梅;《湖北中医杂志》;20060110;第28卷(第1期);第36-37页 * |
金氏肾炎汤加减治疗慢性肾炎30例;李保华;《陕西中医》;20100505;第31卷(第5期);第559-561页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104127752A (zh) | 2014-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178800A (zh) | 一种治疗类风湿性关节炎的中药组合物及其制备方法 | |
CN101396531B (zh) | 一种治疗过敏性紫癜的中药 | |
CN102423423A (zh) | 一种治疗尿路感染的中药 | |
CN104127752B (zh) | 治疗外感风热型肾小球肾炎血尿的中药 | |
CN102861159B (zh) | 一种治疗痛经的药物组合物及其制备方法和用途 | |
CN104225546A (zh) | 一种治疗慢性肾衰竭的中药 | |
CN104042895A (zh) | 一种治疗系统性红斑狼疮的中药组合物及其用途 | |
Pan et al. | [Retracted] Clinical Application of the Classical Theory of Traditional Chinese Medicine in Diabetic Nephropathy | |
CN103655951A (zh) | 一种治疗急性胰腺炎的中药制剂及其制备方法和应用 | |
CN103933430A (zh) | 慢性乙型肝炎药物及其制备方法 | |
CN103948754B (zh) | 一种用于治疗肾虚湿热型慢性肾炎的药物及其制备方法 | |
CN102772697A (zh) | 一种治疗气阴两虚型慢性肾炎的中药 | |
CN106421559A (zh) | 一种治疗高尿酸血症的中药制剂及其制备方法 | |
CN106177163A (zh) | 一种用于治疗瘙痒症的汤剂药物及其制备方法 | |
CN104840865A (zh) | 一种治疗痛风性关节炎的中药制剂 | |
CN104147295A (zh) | 一种治腹泻的中药药剂 | |
CN103007075B (zh) | 一种治疗慢性肾炎的中药组合物 | |
CN103989870A (zh) | 一种治疗痢疾的中药药剂 | |
CN103463483A (zh) | 健脾化湿的治疗水肿的中药组合物及其制备方法 | |
CN103655698B (zh) | 一种治疗银屑病的药物及其应用 | |
CN102836403B (zh) | 一种利用刺梭罗治疗慢性肾炎的中药 | |
CN106880828A (zh) | 一种治疗脾肾气阳虚型原发性肾病综合征的中药组合物 | |
CN106138784A (zh) | 一种治疗面游风的中药组合物及其制备方法 | |
Zhang et al. | A Summary of Lei Genping’s Experience in the Treatment of Chronic Nephritis | |
CN105770354A (zh) | 一种用于治疗慢性肾炎的药物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Zijian Inventor after: Wang Xiangsheng Inventor after: Wei Changzhi Inventor after: Liu Zhihua Inventor after: Zhang Yanmei Inventor before: Wang Xiangsheng Inventor before: Wei Changzhi Inventor before: Liu Zhihua Inventor before: Zhang Yanmei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG XIANGSHENG WEI CHANGZHI LIU ZHIHUA ZHANG YANMEI TO: WANG ZIJIAN WANG XIANGSHENG WEI CHANGZHI LIU ZHIHUA ZHANG YANMEI |
|
CB03 | Change of inventor or designer information |
Inventor after: Wang Xiangsheng Inventor after: Wei Changzhi Inventor before: Wang Zijian Inventor before: Wang Xiangsheng Inventor before: Wei Changzhi Inventor before: Liu Zhihua Inventor before: Zhang Yanmei |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180501 Termination date: 20180823 |